Research
Teaching
Innovation

Clinical neuropsychiatry and neuropsychology

Researchers

  • Anna Planas Ballvé

    Clinical neuropsychiatry and neuropsychology

  • Asunción Ávila

    Clinical neuropsychiatry and neuropsychology

    Phd

  • Dolores Lozano

    Clinical neuropsychiatry and neuropsychology

  • Ester Moral Torres

    Clinical neuropsychiatry and neuropsychology

  • Irati Zubizarreta

    Clinical neuropsychiatry and neuropsychology

    Phd

  • Joan Bello López

    Clinical neuropsychiatry and neuropsychology

    Phd

  • José Vicente Hervas-garcía

    Clinical neuropsychiatry and neuropsychology

    Phd

  • Juan Bernardo Gómez

    Clinical neuropsychiatry and neuropsychology

  • Juan José Mengual

    Clinical neuropsychiatry and neuropsychology

  • Laura Gubieras Lillo

    Clinical neuropsychiatry and neuropsychology

  • Mª Isabel Gómez Ruiz

    Clinical neuropsychiatry and neuropsychology

    Phd

  • Marta Balagué

    Clinical neuropsychiatry and neuropsychology

  • Mercè Leixà

    Clinical neuropsychiatry and neuropsychology

  • Mireia Grau

    Clinical neuropsychiatry and neuropsychology

  • Monica Prat

    Clinical neuropsychiatry and neuropsychology

  • Montse Vacas Moreira

    Clinical neuropsychiatry and neuropsychology

  • Nuria Caballol

    Clinical neuropsychiatry and neuropsychology

  • Pablo Millet Balance

    Clinical neuropsychiatry and neuropsychology

  • Sonia Maria Garcia

    Clinical neuropsychiatry and neuropsychology

  • Xavier Cardona

    Clinical neuropsychiatry and neuropsychology

Contact the group

Form

  • Hervás-García JV, Ramió-Torrentà L, Brieva-Ruiz L, Batllé-Nadal J, Moral E, Blanco Y, Cano-Orgaz A, Presas-Rodríguez S, Torres F, Capellades J, Ramo-Tello C. 193/19

    Comparison of two high doses of oral methylprednisolone for multiple sclerosis relapses: a pilot, multicenter, randomized, double-blind, non-inferiority trial.

    Eur J Neurol. 2019;26(3):525-532.

  • Quirant-Sánchez B, Presas-Rodriguez S, Mansilla MJ, Teniente-Serra A, Hervás-García JV, Brieva L, Moral-Torres E, Cano A, Munteis E, Navarro-Barriuso J, Martínez-Cáceres EM, Ramo-Tello C. 194/19

    Th1Th17(CM) Lymphocyte Subpopulation as a Predictive Biomarker of Disease Activity in Multiple Sclerosis Patients under Dimethyl Fumarate or Fingolimod Treatment

    Inflammatory mediators 2019 Jun 26;2019:8147803.
    DOI

  • Caballol N, Navarro-Otano J, Ávila A, Balagué-Marmaña M, Martínez-Fernández R, de Fàbregas O, Gelpí E, Valls-Solé J, Tolosa E. 48/18

    Myoclonus-Dominant Corticobasal Degeneration.

    Mov Disorder Clin Pract. 2018;5(6):649-652.

  • Compta Y, Giraldo DM, Muñoz E, Antonelli F, Fernández M, Bravo P, Soto M, Cámara A, Torres F, Martí MJ; Catalan MSA Registry (CMSAR). (Ávila A, Caballol N) 67/18

    Cerebrospinal fluid levels of coenzyme Q10 are reduced in multiple system atrophy.

    Parkinsonism Relat Disord 2018;46:16-23.

  • Fernández-Santiago R, Garrido A, Infante J, González-Aramburu I, Sierra M, Fernández M, Valldeoriola F, Muñoz E, Compta Y, Martí MJ, Ríos J, Tolosa E, Ezquerra M, and the Barcelona, ​​LRRK2 study group (Ávila A, and Caballol N, Aguilar M, and Pastor P, Casquero P). 47/18

    α-synuclein (SNCA) but not dynamin 3 (DNM3) influences age at onset of leucine-rich repeat kinase 2 (LRRK2) Parkinson's disease in Spain.

    Mov Disord 2018;33(4):637-641.

  • Garcia-Gorro C, de Diego-BalaguernR, Martínez-Horta S, Pérez-Pérez J, Kulisevsky J, Rodríguez-Dedicha N, Vaquer I, Subira S, Calopa M, Muñoz E, Santacruz P, Ruiz-Idiago J, Mareca C , Caballol N, Camara E. 66/18

    Reduced striato-cortical and inhibitory transcallosal in the motor circuit of Huntington's disease patients.

    Reduced striato-cortical and inhibitory transcallosal in the motor circuit of Huntington's disease patients.

  • Tió E, GAig C, Giner-Soriano M, Romero O, Jurado MJ, Sansa G, Pujol M, Sans O, älvarez-Guerrico I, Caballol N, Jimenez M, Becerra JL, Escartín A, Monasterio C, Molins A, Bove A, Viña J, Iranzo A, Cambrodi R, Calvo G, Morros R, Santamaría J. 68/18

    The prevalence of narcolepsy in Catalonia (Spain).

    J Sleep Res 2018;27(5):e12640.

  • Ávila A, Caballol N, Martí M. 1417

    Simultaneous Classical and Holmes' Tremor in Parkinson's Disease: Involvement of the Cerebellum.

    Can J Neurol Sci. 2017;44(4):436-440.

  • Marchese D, Botta-Orfila T, Cirillo D, Rodriguez JA, Livi CM, Fernández-Santiago R, Ezquerra M, Martí MJ, Bechara E, Tartaglia GG; Catalan MSA Registry (CMSAR). (Ávila A). Bayés À, Botta-Orfila T, Caballol N, Calopa M, Campdelacreu J, Compta Y, Ezquerra M, de Fàbregues O, Fernández-Santiago R, Girado D, Hernández-Vara J, Jaumà S, Marchese D, Martí MJ, Pagonabarraga J, Pastor P, Planellas L, Pont-Sunyer C, Puente V, Pujol M. 1418

    Discovering the 3' UTR-mediated regulation of alpha-synuclein.

    Nucleic Acids Res. 2017; 45 (22): 12888-12903.

  • Ávila A, Cardona X, Martín-Baranera M, León L, Caballol N, Millet P, Bello J. 1245

    Agomelatine for Depression in Parkinson's Disease: Additional Effect on Sleep and Motor Dysfunction.

    J Clin Psychopharmacol. 2015;35(6):719-23.

Projects

    • Year 2020
    • HSDMB

    The Prevalence and Burden of Headache Disorders in the Children and Adolescents of Catalonia.

    • DISTRICT ATTORNEY:

      Dr. Juan Bernardo Gómez Galván

    • TYPE E:

      PINE TREE

    • Year 2020
    • HSDMB

    Observational, transversal, non-interventionist and multicenter study for the characterization of gait in patients with Relapsing-Recurrent Multiple Sclerosis and Secondary Progressive Multiple Sclerosis measured by the sensor system integrated in the FeetMe® insole. MS-FEET Pro,

    • DISTRICT ATTORNEY:

      Novartis Pharmaceuticals SA

    • TYPE E:

      P.S

    • Year 2020
    • HSDMB

    Randomised, double-blind, placebo-controlled, clinical study to evaluate the effect of opicapone 50 mg on Parkinson's disease patients with motor fluctuations and associated pain.

    • DISTRICT ATTORNEY:

      Bial - Portela & Ca, SA

    • TYPE E:

      RD2015

    • Year 2020
    • HSDMB

    Prospective study to evaluate the clinical and immunological evolution of patients with multiple sclerosis in disease-modifying treatment infected versus not infected by SARS-COV-2.

    • DISTRICT ATTORNEY:

      Dr. Luis Brieva Ruiz from the Arnau Hospital in Vilanova de Lleida

    • TYPE E:

      EPA-AS

  • Clinical neuropsychiatry and neuropsychology

    Researcher
    • Year 2019
    • Sant Joan Despí Moisès Broggi Hospital

    Clinical, neuropsychological and neuroimaging characterization of basal ganglia calcification patients.

    • DISTRICT ATTORNEY:

      Anna Planas

    • TYPE E:

      PI

  • Clinical neuropsychiatry and neuropsychology

    Researcher
    • Year 2019
    • Sant Joan Despí Moisès Broggi Hospital

    Monitoring the Mobility of Parkinson's patients with therapeutic purposes - Clinical Trial.

    • DISTRICT ATTORNEY:

      Consorcio Sanitari del Garraf

    • TYPE E:

      PS

  • Clinical neuropsychiatry and neuropsychology

    Researcher
    • Year 2019
    • Hospital General de l'Hospitalet

    Development and linguistic-acoustic analysis of a corpus of spontaneous speech of subjects with DCL and DTA: towards improving diagnosis and early detection,

    • DISTRICT ATTORNEY:

      Mª Isabel Gómez Ruiz

    • TYPE E:

      PI

  • Clinical neuropsychiatry and neuropsychology

    Researcher
    • Year 2019
    • Sant Joan Despí Moisès Broggi Hospital

    Early intervention protocol in patients admitted with alcohol use disorder: Pilot project.

    • DISTRICT ATTORNEY:

      Dr. Monica Prat

    • TYPE E:

      PI

  • Clinical neuropsychiatry and neuropsychology

    Researcher
    • Year 2019
    • Sant Joan Despí Moisès Broggi Hospital

    Observational, prospective, multinational, multicenter study comparing the effectiveness of Safinamide, Rasagiline and other standard treatments as complementary treatment to Levadopa (L-dopa) in patients with fluctuating Parkinson's disease (PD).

    • DISTRICT ATTORNEY:

      Zambon S.p.A

    • TYPE E:

      EPA-SP

  • Clinical neuropsychiatry and neuropsychology

    Researcher
    • Year 2019
    • Hospital General de l'Hospitalet

    Monitoring the Mobility of Parkinson's patients with therapeutic purposes - Clinical Trial.

    • DISTRICT ATTORNEY:

      Consorcio Sanitari del Garraf

    • TYPE E:

      PS

Lines of action

  • Parkinson's disease in our area
  • Psychiatric pathology in neurological diseases
  • Bilingualism in dementia, stroke and movement disorders
  • Multiple Sclerosis: treatment and quality of life
  • Cognitive and fluid biomarkers in neurodegenerative disorders

Documents

Information of interest

Links

Accessibility by WAH